Pay it forward this Giving Tuesday!
Make a gift to The Allergists’ Foundation in honor of a mentor who inspired you.
2025 Medicare Physician Fee Schedule Final Rule
This article summarizes key proposals concerning the Medicare Physician Fee Schedule that impact allergy practices.
2025 MIPS Final Policies
This article summarizes key changes to the traditional Merit-based Incentive Payment System (MIPS) program for the 2025 performance period.
The Allergists’ Foundation’s success in 2024
Together we can grow the program and support projects that make a difference for our specialty, our patients and our communities.
Guidance for payers related to unreasonable documentation for immunotherapy
Read our easy-to-use summary sheet of guidance for payers re reasonable and unreasonable requests for 95165 documentation.
FDA proposes phenylephrine removal from oral OTC drugs
Only a final order will affect which products may be marketed. The proposed order is based on effectiveness concerns, not on safety concerns.
We’ve come a long way
This year, much of our advocacy effort has been devoted to influencing changes to the 2025 Proposed Medicare Physician Fee Schedule.
ACAAI in the News
Here are the recent national media hits for the American College of Allergy, Asthma & Immunology.
Register now for the 2024 Financial Update for Allergists webinar, Weds., Dec. 4 at 7:00 pm CT
Get the latest allergist compensation and E&M coding data. Plus, find revenue-generating opportunities and ways to use artificial intelligence that make fi…
New guidance for payers related to unreasonable documentation for immunotherapy
The recommendations lay out what the authors see as reasonable and unreasonable requests for documentation for allergy immunotherapy services.
… results.
